New and updated preclinical and clinical data presented by biopharma firms at The Liver Meeting of the American Association for the Study of Liver Diseases Nov. 13-16, including: Arbutus, Can-Fite, Dicerna, Gilead, Mallinckrodt, Mirum, Novo, Seal Rock, Theratechnologies, Twoxar